Nanovibronix (NAOV) Competitors $6.46 +0.03 (+0.39%) As of 10:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock NAOV vs. NVNO, ICU, COCH, HSDT, CTCX, NXL, ALUR, IINN, CODX, and SINTShould you be buying Nanovibronix stock or one of its competitors? The main competitors of Nanovibronix include enVVeno Medical (NVNO), SeaStar Medical (ICU), Envoy Medical (COCH), Helius Medical Technologies (HSDT), Carmell (CTCX), Nexalin Technology (NXL), Allurion Technologies (ALUR), Inspira Technologies OXY B.H.N. (IINN), Co-Diagnostics (CODX), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry. Nanovibronix vs. Its Competitors enVVeno Medical SeaStar Medical Envoy Medical Helius Medical Technologies Carmell Nexalin Technology Allurion Technologies Inspira Technologies OXY B.H.N. Co-Diagnostics Sintx Technologies enVVeno Medical (NASDAQ:NVNO) and Nanovibronix (NASDAQ:NAOV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation. Which has preferable earnings & valuation, NVNO or NAOV? Nanovibronix has higher revenue and earnings than enVVeno Medical. enVVeno Medical is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioenVVeno MedicalN/AN/A-$21.82M-$1.20-0.67Nanovibronix$2.34M2.79-$3.70M-$13.53-0.48 Does the media favor NVNO or NAOV? In the previous week, enVVeno Medical had 1 more articles in the media than Nanovibronix. MarketBeat recorded 2 mentions for enVVeno Medical and 1 mentions for Nanovibronix. Nanovibronix's average media sentiment score of 0.95 beat enVVeno Medical's score of 0.53 indicating that Nanovibronix is being referred to more favorably in the news media. Company Overall Sentiment enVVeno Medical Positive Nanovibronix Positive Is NVNO or NAOV more profitable? enVVeno Medical has a net margin of 0.00% compared to Nanovibronix's net margin of -380.29%. Nanovibronix's return on equity of -45.24% beat enVVeno Medical's return on equity.Company Net Margins Return on Equity Return on Assets enVVeno MedicalN/A -57.35% -53.49% Nanovibronix -380.29%-45.24%-34.24% Do institutionals & insiders have more ownership in NVNO or NAOV? 34.7% of enVVeno Medical shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 16.0% of enVVeno Medical shares are owned by insiders. Comparatively, 6.3% of Nanovibronix shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, NVNO or NAOV? enVVeno Medical has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 2.17, meaning that its share price is 117% more volatile than the S&P 500. Do analysts prefer NVNO or NAOV? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Nanovibronix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryNanovibronix beats enVVeno Medical on 7 of the 13 factors compared between the two stocks. Get Nanovibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAOV vs. The Competition Export to ExcelMetricNanovibronixMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.54M$7.07B$6.16B$10.59BDividend YieldN/A1.18%5.73%4.78%P/E Ratio-0.4826.9085.6727.43Price / Sales2.7928.63584.77183.24Price / CashN/A21.7037.3961.86Price / Book0.355.2312.516.79Net Income-$3.70M$178.09M$3.32B$276.90M7 Day Performance-7.51%-1.46%707.60%0.29%1 Month Performance-15.49%6.62%935.16%7.59%1 Year Performance-89.17%4.92%2,403.40%39.41% Nanovibronix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAOVNanovibronix0.415 of 5 stars$6.47+0.4%N/A-88.5%$6.54M$2.34M-0.4820NVNOenVVeno Medical1.0349 of 5 stars$0.95-2.3%N/A-75.3%$18.63MN/A-0.7930ICUSeaStar Medical0.374 of 5 stars$0.66+1.6%N/A-84.5%$18.10M$140K-0.252COCHEnvoy Medical2.6495 of 5 stars$0.81-0.9%$9.25+1,046.5%-63.9%$17.52M$222K-0.5634Analyst RevisionGap UpHSDTHelius Medical Technologies1.0292 of 5 stars$18.19+12.0%N/A-94.4%$17.50M$520K-0.0130CTCXCarmellN/A$0.83+10.7%N/A+52.1%$17.35M$32.84K0.0014NXLNexalin Technology2.6441 of 5 stars$0.93+1.9%$5.00+439.1%+83.1%$16.06M$170K-1.223Gap DownALURAllurion Technologies1.8657 of 5 stars$2.05+1.0%$9.25+351.2%-87.9%$15.91M$19.92M-0.16501IINNInspira Technologies OXY B.H.N.2.4282 of 5 stars$1.19-0.8%$2.00+68.1%-15.9%$15.15MN/A0.0020Gap DownCODXCo-Diagnostics4.4085 of 5 stars$0.38-1.0%$5.50+1,347.4%-69.6%$14.79M$1.00M-0.33100SINTSintx Technologies2.0365 of 5 stars$4.11+4.3%$25.00+508.3%+48.8%$14.74M$950K-0.0840Gap Up Related Companies and Tools Related Companies enVVeno Medical Competitors SeaStar Medical Competitors Envoy Medical Competitors Helius Medical Technologies Competitors Carmell Competitors Nexalin Technology Competitors Allurion Technologies Competitors Inspira Technologies OXY B.H.N. Competitors Co-Diagnostics Competitors Sintx Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAOV) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanovibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanovibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
